Litigation

Recent Posts

Maryland Jury Awards $1.7 Million In 2nd Actos Bladder Cancer Case
Posted on 26 Sep 2013 by Tom Moylan

BALTIMORE — (Mealey’s) A Maryland state court jury on Sept. 26 awarded $1.76 million in the second Actos bladder cancer case to go to trial ( An v. Takeda Pharmaceuticals America, Inc. , No. 24-C12003565, Md. Cir., Baltimore City). ( Verdict... Read More

Tags: Actos , Type 2 diabetes , diabetes drugs , bladder cancer , An v. Takeda Pharmaceuticals America , Litigation , torts , Maryland

Amylin Sues Eli Lilly Over Diabetes Drug Development Deal
Posted on 17 May 2011 by LexisNexis Litigation Resource Community Staff

INDIANAPOLIS - (AP) Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit against Eli Lilly and Co., accusing the larger drugmaker of breaking their commercialization deal for diabetes drugs by teaming with the German company Boehringer Ingelheim... Read More

Tags: drugs , linagliptin , Novo Nordisk , Food and Drug Administration , drugmaker , Eli Lilly , Type 2 diabetes , exenatide , Tradjenta , Amylin , Byetta , Boehringer Ingelheim , diabetes drugs , drug development , Merck , Litigation , lawsuit , Bristol-Myers Squibb , Bydureon

Lawsuits Follow Diabetes Drug Actos' Link To Cancer Risk
Posted on 9 Aug 2011 by LexisNexis Litigation Resource Community Staff

TRENTON, N.J. - (AP) The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals... Read More

Tags: diabetes drug , lawsuits , European Medicines Agency , Weitz &amp , Food and Drug Administration , Luxenberg , Actos , Januvia , Type 2 diabetes , FDA , bladder cancer , Vioxx , Diabetes Care , Merck , Litigation , diabetes , Avandia